lncRNA MALAT1 regulated ATAD2 to facilitate retinoblastoma progression via miR-655-3p.

Zhao, Yuxin; Wang, Zhaoxia; Gao, Meili; Wang, Xuehong; Feng, Hui; Cui, Yuanyuan; Tian, Xia

Zhao, Yuxin; Wang, Zhaoxia; Gao, Meili; Wang, Xuehong; Feng, Hui; Cui, Yuanyuan; Tian, Xia.

Afiliação

Zhao Y; Department of Ophthalmology, Weihai Central Hospital, No. 3, Mishandongluxi, Wendeng District, Weihai, 264400, Shandong, China.
Wang Z; Department of Pediatric, Weihai Central Hospital, Weihai, Shandong, China.
Gao M; Department of Ophthalmology, Weihai Central Hospital, No. 3, Mishandongluxi, Wendeng District, Weihai, 264400, Shandong, China.
Wang X; Department of Ophthalmology, Weihai Central Hospital, No. 3, Mishandongluxi, Wendeng District, Weihai, 264400, Shandong, China.
Feng H; Department of Ophthalmology, Weihai Central Hospital, No. 3, Mishandongluxi, Wendeng District, Weihai, 264400, Shandong, China.
Cui Y; Department of Ophthalmology, Weihai Central Hospital, No. 3, Mishandongluxi, Wendeng District, Weihai, 264400, Shandong, China.
Tian X; Department of Ophthalmology, Weihai Central Hospital, No. 3, Mishandongluxi, Wendeng District, Weihai, 264400, Shandong, China.

Open Med (Wars) ; 16(1): 931-943, 2021.

Article em En | MEDLINE | ID: mdl-34222668

Palavras-chave

ATAD2; MALAT1; miR-655-3p; retinoblastoma; tumor progression

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: Open Med (Wars) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google